A retrospective study assessing efficacy of enteral naloxone (NLX) versus subcutaneous methylnaltrexone (MNTX) for the management of OIC in critically ill patients
Latest Information Update: 03 Nov 2022
At a glance
- Drugs Methylnaltrexone bromide (Primary) ; Naloxone (Primary)
- Indications Constipation
- Focus Therapeutic Use
- 03 Nov 2022 New trial record
- 29 Oct 2022 Results published in the Annals of Pharmacotherapy